Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | ARG2 | P78540 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | TOP1 | P11387 | 1/20 | 0.44 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.43 |
| ▸ | CDK1 | P06493 | 2/20 | 0.43 |
| ▸ | CDK4 | P11802 | 2/20 | 0.43 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.43 |
| ▸ | CCND1 | P24385 | 2/20 | 0.43 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3132480 | 1.00 | MAOB (0.64) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL12809833 | 1.00 | MAOB (0.64) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL8348918 | 0.91 | MAOB (0.58) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL6803904 | 0.91 | MAOB (0.58) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL462351 | 0.85 | MAOB (0.78) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL628859 | 0.85 | MAOB (0.78) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL28043124 | 0.82 | AGXT (0.49) | MAOBCCNB2CDK1CDK4CCNB1 | |
| SCHEMBL27558493 | 0.82 | MAOB (0.74) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL30075910 | 0.82 | MAOB (0.74) | MAOBCA1CA2ARG2MAPK1 | |
| SCHEMBL95697 | 0.79 | MAOB (0.61) | MAOBCA1CA2ARG2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 856 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3017000-B1 | PHENOLIC POLYSULPHIDES HAVING AN IMPROVED ODOUR | ARKEMA FRANCE (FR) | 2024-05-29 | — | — | EP | claimed |
| CN-117447334-A | Method for efficiently synthesizing alpha-amino acetal | 南京工业大学 | 2024-01-26 | — | — | CN | claimed |
| CN-115460933-A | Flavour composition for improving taste impression | 西姆莱斯有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-108651471-A | A kind of preparation method of timber sterilization antiseptic | 长乐智高生物科技有限公司 | 2018-10-16 | — | — | CN | claimed |
| EP-2847318-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | Marrone Bio Innovations, Inc. (US) | 2015-03-18 | — | — | EP | claimed |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | PRO FARM GROUP, INC. | 2015-01-29 | — | — | US | claimed |
| WO-2013138398-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES | MARRONE BIO INNOVATIONS, INC. (US) | 2013-09-19 | — | — | WO | claimed |
| CN-101462947-B | Preparation of (R) -4-phenyl-2-hydroxybutyrate | SHANGHAI BAIDING PHARMACEUTICAL TECHNOLOGY CO LTD | 2012-07-25 | — | — | CN | claimed |
| EP-2411004-A1 | USE OF ANDROGRAPHOLIDE COMPOUNDS FOR TREATING INFLAMMATION AND AIRWAY DISORDERS | National University of Singapore (SG) | 2012-02-01 | — | — | EP | claimed |
| US-20120015923-A1 | USE OF ANDROGRAPHOLIDE COMPOUNDS FOR TREATING INFLAMMATION AND AIRWAY DISORDERS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2012-01-19 | — | — | US | claimed |
| WO-2010110748-A1 | USE OF ANDROGRAPHOLIDE COMPOUNDS FOR TREATING INFLAMMATION AND AIRWAY DISORDERS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2010-09-30 | — | — | WO | claimed |
| CN-101462947-A | Preparation of (R) -4-phenyl-2-hydroxybutyrate | SHANGHAI BAIDING PHARMACEUTICA (CN) | 2009-06-24 | — | — | CN | claimed |
| US-7375081-B2 | Therapeutic combination of a pneumocandin derivative and an antifungal agent | ASTELLAS PHARMA INC. (JP) | 2008-05-20 | — | — | US | claimed |
| US-6875740-B1 | Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2005-04-05 | — | — | US | claimed |
| US-5302608-A | Antidiabetic, anticholesterol agents; vision disorders | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-04-12 | — | — | US | claimed |
| US-4861815-A | BLENDS | BAYER AKTEINGESELLSCHAFT (DE) | 1989-08-29 | — | — | US | claimed |
| CN-120076993-A | Aerosol dispenser and nozzle | 宝洁公司 | 2025-05-30 | — | — | CN | disclosed |
| US-12220677-B2 | Process for the preparation of microcapsules | SYMRISE AG (DE) | 2025-02-11 | — | — | US | disclosed |
| US-4410730-A | Process for the production of o-(N-monosubstituted amino)benzyl alcohols | SHIONOGI & CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4073813-A | PLATINUM REDUCTION CATALYST, ALDEHYDES, HYDROGEN | RHONE-POULENC INDUSTRIES (FR) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015923-A1 | USE OF ANDROGRAPHOLIDE COMPOUNDS FOR TREATING INFLAMMATION AND AIRWAY DISORDERS | NFKBIA, CCL11, IL5 | MAOB 2649/4885CA1 3534/4885CA2 2983/4885 |
| US-20150031534-A1 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | BLVRB, PRDX6, ACHE | MAOB 224/4885CA1 4277/4885CA2 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.